The antibiotic resistome: challenge and opportunity for therapeutic intervention

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Infectious diseases remain a major cause of mortality and morbidity globally.
• The development of new antibacterial agents is not a high priority for pharmaceutical companies due to regulatory and economic challenges.
• Increasing antibiotic resistance necessitates novel approaches to antimicrobial drug discovery.

Purpose of the Study:

• To explore the potential of targeting bacterial resistance mechanisms for new drug development.
• To identify elements contributing to bacterial antibiotic susceptibility as potential drug targets.
• To review current strategies and future possibilities in combating antibiotic resistance.

Main Methods:

• Analysis of bacterial intrinsic resistomes.
• Review of inhibitors of resistance mechanisms currently under development.
• Discussion of novel therapeutic strategies involving metabolic intermediates.

Main Results:

• Bacterial resistance mechanisms present viable targets for novel antibacterial development.
• Understanding intrinsic resistomes aids in identifying key elements for drug targeting.
• Inhibitors of resistance and metabolic modulators show potential for enhancing antibiotic efficacy.

Conclusions:

• Targeting bacterial resistance mechanisms is a key strategy to overcome the antimicrobial resistance crisis.
• Further research into intrinsic resistomes and novel therapeutic approaches is essential.
• Combining antibiotics with agents that alter bacterial physiology may restore susceptibility and combat resistance.